Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage
- Conditions
- HypertensionDiabetesAnesthesia
- Registration Number
- NCT02864212
- Lead Sponsor
- Coordinación de Investigación en Salud, Mexico
- Brief Summary
The aim of this observational study is to create a data base to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.
- Detailed Description
The aim of this observational study is to create a database to extract feature of fast-acting drugs that can be monitor in real time to design control strategies based on high order sliding mode controller to create a robust drug infusion system.
The observed drugs in this study are fast acting insulin, propofol and sodium nitroprusside.
The effect of insulin will be measured by a continuous glucose monitor, the effect of propofol by a bispectral index monitor and the the effect of sodium nitroprusside by a invasive blood pressure monitor.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- American Society of Anesthesiologists (ASA) physical status I, II, II
- Impossibility to measure depth of anesthesia or invasive blood pressure. Impossibility of using glucose monitor.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glucose Every 5 minutes during 3 days. The glucose will be measured by a continuous glucose monitor. For the group of patients for diabetes.
Note: This protocol has three primary outputs because its objective is to create a database of each output to analyze the response to the associated drug (insulin, propofol and sodium nitroprusside.Bispectral Index Every second during surgery Depth of anesthesia will be measured by a Bispectral Index monitor.
Invasive blood pressure Every 5 minutes during surgery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Unidad de Investigación Médica en Enfermedades Metabólicas IMSS
🇲🇽Mexico, Mexico City, Mexico